April 7, 2004 |
A federal appeals court upheld Genentech Inc.'s legal victory in a $1-billion patent battle with Bay Area biotechnology rival Chiron Corp., Genentech said Tuesday. In 2002, a federal jury unanimously decided Emeryville, Calif.-based Chiron had no claim to share any profit from Genentech's blockbuster breast cancer drug Herceptin. Chiron appealed the ruling.
January 19, 2006 |
Microsoft Corp. plans to ask for a new judge to preside over a federal patent trial in which it would try to avoid paying $521 million in damages. The U.S. Court of Appeals for the Federal Circuit, without comment, said Microsoft could appeal U.S. District Judge James B. Zagel's refusal to step down from the case that centers on whether the company's Internet Explorer browser infringes a patent.
September 8, 2005 |
A U.S. appeals court upheld a $164.2-million verdict against Tyco International Ltd.'s Nellcor unit in a lawsuit filed by rival Masimo Corp. over machines that measure the oxygen content in blood. The U.S. Court of Appeals for the Federal Circuit in Washington also said the trial judge should have ordered Nellcor to stop selling pulse oximetry machines and directed her to issue a ban on such sales. The suit is one of several between the two companies over oximetry machines.
September 20, 2007 |
Microsoft Corp. won its bid to have a patent-infringement lawsuit by creditors of defunct Internet service provider At Home Corp. thrown out. The U.S. Court of Appeals for the Federal Circuit ruled in Washington that a trust set up to pay At Home's creditors lacked authority to sue Microsoft over a patent they received to pay bankruptcy claims. The court ruled that U.S.
September 27, 2007 |
Verizon Communications Inc., the No. 2 U.S. phone company, won an appeals court ruling upholding most of a patent verdict over rival Vonage Holdings Corp., the second legal setback for Vonage in two days. The U.S. Court of Appeals for the Federal Circuit in Washington also upheld a court order barring Vonage's use of Verizon's inventions, including a way of connecting Internet calls to standard phone lines. The order blocking use of the inventions had been on hold pending the appeal.
October 16, 2007 |
A federal judge indicated Monday that he would reverse his decision to double a $19.6-million damage award for Broadcom Corp. in a patent dispute with rival chip maker Qualcomm Inc. because a legal standard had changed. U.S. District Judge James Selna in Santa Ana issued a tentative ruling in which he said an appeals court changed the law he had applied. Selna on Aug. 10 had doubled the award to $39.3 million because Qualcomm's patent infringement was found to be deliberate. On Aug. 20, the U.S.
January 22, 2005 |
A U.S. appeals court Friday limited the ability of generic-drug companies to challenge patents in a ruling affecting Pfizer Inc.'s antidepressant Zoloft. Teva Pharmaceutical Industries Ltd. sought to challenge Pfizer's patent on a method of making Zoloft so that the Israeli company could begin selling a generic version when the patent protecting the chemical composition of the drug expired in 2006. The U.S.
September 20, 2008 |
Qualcomm Inc. must face an additional claim of patent infringement made by Broadcom Corp. before the U.S. International Trade Commission in Washington, an appeals court ruled Friday. The U.S. Court of Appeals for the Federal Circuit revived a claim that had been thrown out, involving a patent for transmitting radio frequency signals, against one type of Qualcomm chip.